The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice.

Neutropenia and impairment of neutrophil function are commonly observed in patients with human immunodeficiency virus (HIV) infections. The HIV regulatory protein Tat is known to exert immunosuppressive effects. Alcohol is known also to be an immunosuppressive factor, and as alcohol abuse is common among HIV infected hosts, both factors may interact in an additive or synergistic fashion to further impair the host defenses of these patients. In order to test this possibility, endotoxin-induced neutrophil beta2-integrins CD11b and CD18 expression, phagocytosis, and hydrogen peroxide generation were examined in normal and HIV-1 Tat-transgenic mice in the absence and presence of ethanol intoxication. Acute ethanol intoxication was induced in mice (body weight of 25+/-1 g) by an intraperitoneal (ip) injection of ethanol (3 g/kg, 20% in normal saline). Thirty min later, the animals were given an ip injection of endotoxin (20 microg in 0.2 ml of saline/mouse). Vehicle-treated controls received an ip injection of saline without ethanol or endotoxin. Two hr after endotoxin administration, the animals were killed to determine neutrophil functions with flow cytometry. The baseline expression of CD11b and CD18 was similar in normal nontransgenic and Tat-transgenic mice. Endotoxin administration significantly up-regulated CD11b and CD18 expression in normal mice. This up-regulation was suppressed in Tat-transgenic mice. Ethanol intoxication inhibited endotoxin-induced CD11b and CD18 expression in normal mice and totally abolished endotoxin-induced CD11b and CD18 expression in Tat-transgenic mice. Neutrophil phagocytic activity in normal and Tat-transgenic mice was similar. Ethanol intoxication produced a similar inhibition of phagocytosis in both study groups. Endotoxin suppressed phagocytosis in normal mice, and this suppression was more pronounced in Tat-transgenic mice. Spontaneous and phorbol myristate acetate (PMA)-stimulated hydrogen peroxide generation by circulating neutrophils (PMNs) were similar in normal and Tat-transgenic mice. Neither ethanol nor endotoxin affected hydrogen peroxide generation by PMNs. These data show that both Tat and alcohol significantly impair PMN function, and this may be a mechanism leading to the increased susceptibility of the HIV-infected host to bacterial infection.

[1]  G. Warr,et al.  Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. , 2015, The American review of respiratory disease.

[2]  B. Joshi,et al.  The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. , 1997, Archives of biochemistry and biophysics.

[3]  I. Hewlett,et al.  HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. , 1996, Journal of immunology.

[4]  O. Prakash,et al.  Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice. , 1996, Journal of immunology.

[5]  L. Vaca,et al.  Modulation of cell membrane potential in cultured vascular endothelium. , 1996, The American journal of physiology.

[6]  I. Hewlett,et al.  HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. , 1996, Journal of immunology.

[7]  R. Chaisson,et al.  Neutropenia and bacterial infection in acquired immunodeficiency syndrome. , 1995, Archives of internal medicine.

[8]  Ping Zhang,et al.  ATTENUATION OF HEPATIC NEUTROPHIL SEQUESTRATION BY ANTI‐CINC ANTIBODY IN ENDOTOXIC RATS , 1995, Shock.

[9]  A. Laursen,et al.  Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. , 1995, The Journal of infectious diseases.

[10]  R. Gallo,et al.  Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. , 1995, Journal of biomedical science.

[11]  F. Bistoni,et al.  Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. , 1995, The Journal of infectious diseases.

[12]  M. Dierich,et al.  Interaction of several complement proteins with gp120 and gp41, the two envelope gycoproteins of HIV‐1 , 1995, AIDS.

[13]  O. Prakash,et al.  Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity. , 1994, International journal of immunopharmacology.

[14]  S. Capitani,et al.  Recombinant human immunodeficiency virus type‐1 (HIV‐1) Tat protein sequentially up‐regulates IL‐6 and TFG‐β1 mRNA expression and protein synthesis in peripheral blood monocytes , 1994, British journal of haematology.

[15]  Ping Zhang,et al.  HEPATIC NEUTROPHIL SEQUESTRATION IN EARLY SEPSIS: ENHANCED EXPRESSION OF ADHESION MOLECULES AND PHAGOCYTIC ACTIVITY , 1994, Shock.

[16]  O. Bagasra,et al.  Human studies on alcohol and susceptibility to HIV infection. , 1994, Alcohol.

[17]  C. Ambrosino,et al.  The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein , 1994, The Journal of experimental medicine.

[18]  N. Liabakk,et al.  Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .

[19]  R. Watson,et al.  Diet and ethanol modulate immune responses in young C57BL/6 mice. , 1993, Alcoholism, clinical and experimental research.

[20]  L. A. Avdeeva,et al.  Impact of HIV‐Positive Sera on the Functional Activity of Polymorphonuclear Neutrophils from Healthy Donors , 1993, Scandinavian journal of immunology.

[21]  L. Buonaguro,et al.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines , 1992, Journal of virology.

[22]  B. Aggarwal,et al.  Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. , 1992, Lymphokine and cytokine research.

[23]  M. Lederman,et al.  Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. , 1992, Cellular immunology.

[24]  M. Wulfsohn,et al.  A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome , 1990 .

[25]  C. Pettinelli,et al.  Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study. , 1990, Annals of internal medicine.

[26]  G. Bagby,et al.  The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. , 1989, The Journal of infectious diseases.

[27]  M. Cairo,et al.  Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. , 1988, The Journal of infectious diseases.

[28]  R. Holman,et al.  Comparison of Methods for Assessing Chemotaxis of Monocytes and Polymorphonuclear Leukocytes Isolated From Patients With AIDS or AIDS‐Related Conditions , 1988, Journal of leukocyte biology.

[29]  C. Maury,et al.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. , 1988, The American journal of medicine.

[30]  A. Fauci,et al.  Impairment of neutrophil bactericidal capacity in patients with AIDS. , 1988, The Journal of infectious diseases.

[31]  D. Linch,et al.  Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection , 1987, British journal of haematology.

[32]  J. Sodroski,et al.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication , 1986, Cell.

[33]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[34]  P. Hermans Clinical use of haematological growth factors in patients with human immunodeficiency virus (HIV-1) infection. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  D. Gabrilovich,et al.  Clinical significance of neutrophil functional activity in HIV infection. , 1994, Scandinavian journal of infectious diseases.

[36]  B. Berkhout,et al.  Regulation of HIV expression: mechanisms of action of Tat and Rev. , 1991, AIDS.

[37]  G. Bagby,et al.  Alcohol suppresses lipopolysaccharide-induced tumor necrosis factor activity in serum and lung. , 1989, Life sciences.

[38]  M. Gonda,et al.  The trans-activator gene of HTLV-III is essential for virus replication , 1986, Nature.

[39]  S. Taniuchi,et al.  A quantitative assay of oxidative metabolism by neutrophils in whole blood using flow cytometry. , 1985, Journal of immunological methods.

[40]  R. Macgregor,et al.  Effect of acute alcohol intoxication on granulocyte mobilization and kinetics. , 1978, Blood.